PMOS linked to increased risk of reproductive cancers

A large-scale US study involving over 2.5 million women has linked Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as Polycystic Ovary Syndrome (PCOS), to an increased risk of several female reproductive cancers. Using the Optum Clinformatics Data Mart database to analyze over 400,000 women with PMOS, researchers found that those with the condition faced significantly higher hazards for uterine, ovarian, fallopian tube, breast, and cervical cancers compared to those without the syndrome.

The study noted the strongest association with uterine cancer, where the hazard was nearly six times higher. It also identified a 4.38-fold increased risk for ovarian or fallopian tube cancer, a 2.66-fold risk for breast cancer, and a 2.22-fold risk for cervical cancer. This represents the first study to suggest such an increased hazard for cervical cancer among women with PMOS.

On a personal level, public health advocates are highlighting the need for better education and specialized care for PMOS. Zeest Mahmood Jalib, a graduate student at the Harvard T.H. Chan School of Public Health, is working to empower women through health knowledge, aiming to create professional support spaces for women in Pakistan to address the condition and its societal impacts.